Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma

Fig. 5

ROC analysis of the predictive performance and nomogram construction for early recurrence of the 25-lncRNA risk signature, TNM stage, vascular invasion and AFP. A-B) ROC analysis of the predictive performance of the 25-lncRNA risk signature, TNM stages, vascular invasion and AFP for 1-year DFS (A) and 2-year DFS (B) in the entire TCGA cohort; C-D) ROC analysis of the predictive performance of the combination of the 25-lncRNA risk signature, TNM stages, vascular invasion and AFP and risk score alone for 1-year DFS (C) and 2-year DFS (D) in the entire TCGA cohort. E) Nomogram of the 25-lncRNA signature risk score combined with AFP, vascular invasion and TNM stages; F) Calibration curves for the 25-lncRNA-signature-integrated nomogram for 1-year DFS and 2-year DFS. RS: the risk score of the 25-lncRNA signature, VI: vascular invasion

Back to article page